Back to Agenda
The Covid -19 Digital Response of Countries and Companies: What is Here to Stay?
Session Chair(s)
Jessica Federer, MPH
Board Member
Sage Therapeutics, United States
History is being made by both countries and companies when it comes to COVID-19 digital deployments. Hear from leaders of these ground breaking initiatives about what these activities mean for the future of life science research.
Learning Objective : Demonstrate elements of both national deployments of COVID-19 digital solutions and global digital-first COVID-19 clinical trials; Evaluate opportunities from the perspectives of participants in these historic deployments, including regulators, national providers/payers, clinical research organizations, digital health companies, and life science companies.
Speaker(s)
Panelist
Michelle Hoiseth
Cytel, United States
General Manager, Project-Based Services
Panelist
Tara Donnelly
NHSX, United Kingdom
Chief Digital Officer
Have an account?